Stanford, CANCT07010614Now EnrollingIRB Ready

Schizophrenia Disorders Clinical Trial in Stanford, CA

Access cutting-edge schizophrenia disorders treatment through this clinical trial at a research site in Stanford. Study-provided care at no cost to qualified participants.

Sponsored by Stanford University

Quick Self-Assessment

See if you qualify for this Stanford location

Preparing your pre-screening questions…

Expert Care in Stanford

Access schizophrenia disorders specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related schizophrenia disorders treatment provided free

Apply for This Stanford Location

Check if you qualify for this schizophrenia disorders clinical trial in Stanford, CA

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Stanford

    Convenient for CA residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Stanford site if eligible
  4. 4Begin participation

About This Schizophrenia Disorders Study in Stanford

Schizophrenia - marked by delusions, hallucinations, and cognitive deficits - causes the most disability of any mental health condition, but existing treatments have significant side effect burden and are often ineffective. Disordered neural activity in the hippocampus likely contributes to schizophrenia symptoms, but to develop better therapies we need to understand whether hippocampal activity in schizophrenia can be systematically affected by non-invasive brain stimulation techniques like transcranial magnetic stimulation (TMS). This proposal will investigate the use of connectivity-guided theta burst brain stimulation to specifically target hippocampal function in schizophrenia, offering insights into fundamental hippocampal processes, schizophrenia pathophysiology, and potential avenues to use brain stimulation as a therapeutic tool in this devastating illness.

Sponsor: Stanford University

Who Can Participate

Inclusion Criteria

Men and women, ages 18 to 65 years
Medically intractable epilepsy requiring phase II monitoring (intracranial EEG arms only)
DSM-V diagnosis of schizophrenia spectrum Axis I disorders including delusional disorder, brief psychotic disorder, schizophreniform disorder, schizophrenia, schizoaffective disorder (non-invasive TMS-EEG arms only).
Must have intellectual capacity to ensure adequate comprehension of the study and potential risks involved in order to provide informed consent
No current or history of major neurological disorders other than epilepsy.

Exclusion Criteria

DSM5 diagnosis of intellectual disability
Significant head injury
Active suicidal ideation or history of suicide attempt within the past 1 year.
Medical illness affecting brain structure or function, or other uncontrolled or unstable medical condition.
Pregnancy or postpartum (\<6 weeks after delivery or miscarriage)
Inability to provide informed consent
Active substance abuse other than alcohol or cannabis within the past 1 year
Psychotic illness with a temporal relation to substance use or head injury
Those with a contraindication for MRIs or TMS (e.g. implanted metal).

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Stanford?

Yes, this clinical trial (NCT07010614) has an active research site in Stanford, CA that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Schizophrenia Disorders Treatment Options in Stanford, CA

If you're searching for schizophrenia disorders treatment options in Stanford, CA, this clinical trial (NCT07010614) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Stanford research site is actively enrolling participants for this clinical trial. You'll receive care from experienced schizophrenia disorders specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all schizophrenia disorders clinical trials near you to find additional studies recruiting in your area.

More Schizophrenia Trials in Stanford, CA

See all schizophrenia clinical trials recruiting in Stanford — not just this study.

Browse Schizophrenia Trials in Stanford →

Ready to Join in Stanford?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Stanford, CA